Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator
about
A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansCritical role of toxicologic pathology in a short-term screen for carcinogenicityScientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment.Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of actionIdentification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendiumSmall-molecule modulators of the constitutive androstane receptor.Small-molecule modulators of PXR and CAR.RNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome.Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cellsActivation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma TreatmentA critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans.Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor.Mode of action analysis for pesticide-induced rodent liver tumours involving activation of the constitutive androstane receptor: relevance to human cancer risk.The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events.A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis.Contribution of new technologies to characterization and prediction of adverse effects.Risk assessments for chronic exposure of children and prospective parents to ethylbenzene (CAS No. 100-41-4).Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.Mode of action analysis for rat hepatocellular tumors produced by the synthetic pyrethroid momfluorothrin: evidence for activation of the constitutive androstane receptor (CAR) and mitogenicity in rat hepatocytes.Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants.An Evaluation of the Human Relevance of the Lung Tumors Observed in Female Mice Treated With Permethrin Based on Mode of Action.Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR/hPXR mice.Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation.Pathway Based Toxicology and Fit-for-Purpose Assays.Relationship of Metabolism and Cell Proliferation to the Mode of Action of Fluensulfone-Induced Mouse Lung Tumors. II: Additional Mechanistic Studies.Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.Role of CYP2B in Phenobarbital-Induced Hepatocyte Proliferation in Mice.Exposure to perfluoroundecanoic acid (PFUnDA) accelerates insulitis development in a mouse model of type 1 diabetes.From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.Involvement of Mouse Constitutive Androstane Receptor in Acifluorfen-Induced Liver Injury and Subsequent Tumor Development.Dose and Effect Thresholds for Early Key Events in a PPARα-Mediated Mode of Action.Mechanistic Investigation of Toxaphene Induced Mouse Liver Tumors.Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver.Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors.Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway.Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor.Sedaxane-Use of Nuclear Receptor Transactivation Assays, Toxicogenomics, and Toxicokinetics as Part of a Mode of Action Framework for Rodent Liver Tumors.Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.Interleukin-6 Induces DEC1, Promotes DEC1 Interaction with RXRα and Suppresses the Expression of PXR, CAR and Their Target Genes.
P2860
Q28072372-80957188-E45F-4EAC-BA29-63AEBE10B3EDQ28075960-AA502E2C-A7F2-40DF-8BE0-E73BCFBB5F5FQ30938639-FC61EA17-3EAC-47FC-8F20-E4F509440A6DQ33872745-9BF7A4D3-2F87-4F54-9FD3-7BA2EED4EAE3Q35575682-CF1CDB2A-8FD6-4BE2-A79B-A6ACBBD91602Q35748820-E83D0638-0266-4153-AAD2-50C6CF258E6DQ35938150-9323AB1C-E16C-4211-941F-3EC071B87569Q35998854-36A0039C-F48B-4EAF-9343-633B189A1283Q36145585-FC4DA260-FDC2-48C7-A9B8-9E8FE29DD3E1Q36665092-0B487B28-3EE6-404C-A808-920E1B334691Q38209158-38BC0F25-E6D3-49B4-B792-02754FE132BAQ38212105-18367DC5-1EA8-48FD-A815-930793E126A7Q38232042-15DF501C-B981-42EA-91D4-AB073B95FE8BQ38234794-B33E32F0-B9F5-4539-9F9D-89B89A3CEE21Q38327212-44592BC3-0F88-43B9-AD65-FD14A296D7C9Q38329939-D2E44A5A-6DC9-4212-8E2E-360D7E09F1C7Q38495604-876D7CAA-76BF-4757-AD11-9669C0ADDB9FQ38687132-A97D9680-7655-49A5-BFD6-C8CDA86502C7Q38755871-988712DC-85F3-4FA4-9E01-D7FEF42D5D41Q38777001-56FB33A3-5184-4FD2-9931-F2C225F8EBB1Q38791097-06068D7C-6FA3-444C-9B57-4C328AF17508Q38826418-E84265FD-6C7D-43C6-8802-D844080DE465Q39037022-55B366BC-43A5-4ABF-9B56-9454DCCB08BBQ39311280-BF222B30-E63B-4FA9-8E4C-3191AC35FCCBQ39348556-5E13729C-0475-41BC-962F-2BDD6D1B43B2Q39412227-9C9ABC90-6189-4688-9950-5FEA332E533BQ40030443-75E0FCBC-D6FE-4CFB-9F41-209DCE74DEC0Q41069298-6A3BD6A7-B3CB-473F-AB40-AFF2BC8BE9E2Q41679312-842AA1D4-5BFF-455E-B475-CEF71A2C8C2CQ42511311-405B19A2-EA5B-4BA4-8D93-E9CB00DD8D94Q42699309-A078440A-2DA2-456F-A3DC-AC38F5D74D60Q42700243-EFABFFB0-CAB2-48B0-9C96-11CBE68BFE49Q42701176-84977235-8BDF-49FE-8693-67AA715DB660Q42704422-6FAA0234-FB6B-437A-8CF4-BCF76A927A4FQ42706153-7AC8C0AE-8886-4106-BEB7-007063887C58Q42707254-B9A6354F-99E0-4D3B-BAA3-496BAB5F7D0CQ45437689-C2595091-5054-4A91-9B8C-A1E818654B0CQ46240446-3423338F-9700-4B0A-8097-A8B49965A324Q46844112-237B48FD-D62A-4F7A-B952-DC93AEA4EF04Q47163604-7B6BA87A-03F5-4649-8FC7-F4B682E33F25
P2860
Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mode of action and human relev ...... stane receptor (CAR) activator
@ast
Mode of action and human relev ...... stane receptor (CAR) activator
@en
type
label
Mode of action and human relev ...... stane receptor (CAR) activator
@ast
Mode of action and human relev ...... stane receptor (CAR) activator
@en
prefLabel
Mode of action and human relev ...... stane receptor (CAR) activator
@ast
Mode of action and human relev ...... stane receptor (CAR) activator
@en
P2093
P2860
P1476
Mode of action and human relev ...... stane receptor (CAR) activator
@en
P2093
Abigail Jacobs
Amber Goetz
Brian G Lake
Clifford R Elcombe
Curtis J Omiecinski
David Bell
David Geter
Douglas C Wolf
Jason Bailey
Jay I Goodman
P2860
P356
10.3109/10408444.2013.835786
P407
P577
2013-11-04T00:00:00Z